Equity Risk Sciences Introduces Groundbreaking Stock Risk Ratings to Aid Fiduciaries

Equity Risk Sciences (ERS) has emerged as America's inaugural independent Stock Risk Rating Agency, introducing a novel approach to evaluating stock price volatility through quantitative, evidence-based ratings. Utilizing proprietary models that analyze SEC-filed financial data and 35 years of price history, ERS aims to provide fiduciaries and institutional investors with objective, conflict-free analysis to navigate the complexities of stock investments.

At the core of ERS's offerings are two pivotal ratings: the Fiduciary Stock Navigator (FSN) and the Loss Indicator (LI). The FSN offers a comprehensive assessment of a stock's fiduciary suitability and likelihood of significant loss, while the LI focuses on financial statement strength and deterioration, pinpointing companies with heightened economic vulnerability. These ratings are derived from rigorous statistical analysis, highlighting the historical correlation between financial statement deterioration and future stock price declines.

ERS's launch is timely, addressing the critical need for fiduciaries to access objective data amidst increasing regulatory scrutiny. The agency's ratings, including the 'A+' for stocks with strong financials and low downside risk, and the '-3' for those with significant financial risk, are backed by a 25-year study of over 400,000 stock ratings. This data underscores the importance of financial fundamentals in preventing major losses, challenging the notion that such declines are an inevitable part of long-term investing.

Raymond Mullaney, Founder and CEO of ERS, emphasizes the agency's commitment to providing actionable risk ratings grounded in economic reality, stating, 'Our goal is to give fiduciaries the tools they need to avoid preventable losses.' With its launch, ERS sets a new standard for fiduciary oversight and portfolio risk management, empowering professionals to make informed decisions based on data science and AI.